Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is considerable evidence that its underlying cause is inflammatory in nature [678-686]”
Citations
Cites
1 retracted
Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T., & Ideura, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12229-5 · Cited by 970
RetractedGlobal Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311 · cited 1×
“dtd"> Isolated diabetes mellitus is a frequent and increasing public health problem”
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873 · cited 1×
“The beneficial effect of blockade of the renin–angiotensin–aldosterone system (RAAS) is therefore not only for blood pressure reduction but also for end-organ protection in patients with type-II diabetes”
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465 · cited 1×
“For example, C-reactive protein (an inflammatory marker) has been related to insulin resistance, blood pressure, HDL, and triglyceride, and to markers of endothelial damagesdysfunction (plasma levels of von Willebrand factor, tissue plasminogen activator, and cellular fibronectin)”
Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,037 · cited 1×
“15 In the CALM (Candesartan and Lisinopril Microalbuminuria) study, addition of an ARB to an ACE inhibitor did achieve added benefits on blood pressure and microalbuminuria”
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652 · cited 1×
“4 The pathophysiology of cardiovascular disease in subjects with diabetes is multifactorial, and in addition to the classic risk factors (such as hypertension, dyslipidaemia and obesity) in type-II diabetes, increased urinary albumin excretion, endothelial dysfunction, and chronic inflammation are inter-related proces…”
CD40 Signaling and Plaque Instability
Schönbeck, U., & Libby, P. (2001) · Circulation Research · doi:10.1161/hh2401.101272 · Cited by 566 · cited 1×
“27 Finally, recent data have implicated interactions between the expression andsor soluble levels of CD40 and CD40 ligand (CD40L or officially termed CD154) in the pathogenesis of atherothrombotic complications (and prognosis) in cardiovascular disease (CVD), as well as to inflammation and thrombosis, although the mea…”
Stehouwer, C. A., Zeldenrust, G. C., den Ottolander, G. H., Hackeng, W. H. L., Donker, A. J. M., & Nauta, J. J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)91401-s · Cited by 560 · cited 1×
“18 Why should the endothelium be relevant? Microalbuminuria has been related to endothelial damagesdysfunction”
Jager, A., van Hinsbergh, V. W., Kostense, P. J., Emeis, J. J., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. (2000) · Diabetes · doi:10.2337/diabetes.49.3.485 · Cited by 214 · cited 1×
“25 Although not specific for the endothelium, levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) have also been reported to be independently associated with the risk of cardiovascular mortality in type-II diabetic subjects”
Lim, H. S., Blann, A. D., & Lip, G. Y. H. (2004) · Circulation · doi:10.1161/01.cir.0000129773.70647.94 · Cited by 203 · cited 1×
“28 In a study of 97 patients with diabetes mellitus and 39 comparable healthy controls, we recently found that plasma levels of sCD40L, soluble P-selectin (an index of platelet activation), interleukin-6 (an inflammatory cytokine), and tissue factor (an initiator of coagulation) were higher in subjects with diabetes c…”
Self-citationSavage, S., Estacio, R. O., Jeffers, B., & Schrier, R. W. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1243 · Cited by 176 · cited 1×
“If present, microalbuminuria identifies patients at risk for early cardiovascular death, as well as those who would indeed have a significantly increased risk of microvascular complications, such as retinopathy and neuropathy”
O’Driscoll, G., Green, D., Maiorana, A., Stanton, K., Colreavy, F., & Taylor, R. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00065-0 · Cited by 174 · cited 1×
“22 and antihypertensive treatment with drugs such as the ACE inhibitors may improve both stimulated and basal nitric oxide-dependent endothelial function in subjects with type-II diabetes mellitus”
AGARDH, C. ‐., García‐Puig, J., Charbonnel, B. H., Angelkort, B., & Barnett, A. H. (1996) · PubMed · Cited by 139
Nomura, S., Kanazawa, S., & Fukuhara, S. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001447 · Cited by 121 · cited 1×
“26 sVCAM-1, alongside another nonspecific marker (soluble ICAM-1 and) endothelial-specific E-selectin levels have all been shown to be higher in the hypertensive patients, especially in hypertensive patients with diabetes”
Cost of poor blood pressure control in the UK: 62 000 unnecessary deaths per year
He, F. J., & MacGregor, G. A. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001581 · Cited by 106 · cited 1×
“This would prevent approximately 21 400 stroke deaths and 41 400 ischaemic heart disease deaths each year — thus, approximately 42 800 strokes and 82 800 ischaemic heart diseases saved, making a total of 125 600 events saved per year in the UK”
Fogari, R., Zoppi, A., Corradi, L., Mugellini, A., Lazzari, P., Preti, P., & Lusardi, P. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000732 · Cited by 96
Ito, A., Egashira, K., Narishige, T., Muramatsu, K., & Takeshita, A. (2002) · Circulation Journal · doi:10.1253/circj.66.811 · Cited by 78 · cited 1×
“Indeed, ACE activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type-II diabetes mellitus”
Vehkavaara, S., & Yki-Järvinen, H. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000113817.48983.c5 · Cited by 76 · cited 1×
“23 Insulin therapy has also been shown to improve endothelium-dependent and endothelium-independent vasodilatation”
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension
Leoncini, G., Sacchi, G., Ravera, M., Viazzi, F. C., Ratto, E., Vettoretti, S., Parodi, D., Bezante, G. P., Sette, M. D., Deferrari, G., et al. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001408 · Cited by 74 · cited 1×
“Indeed, use of the albumin-to-creatinine ratio is recommended as the preferred screening strategy for all diabetic patients, as it can be simply measured and, disappointingly, commonly overlooked as a screening tool in clinical medicine”
Diabetes and hypertension physiopathology and therapeutics
Contreras, F., Rivera, M., Vásquez, J. M. R., la Parte, M. D., & Velasco, M. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000983 · Cited by 71
Tan, K. C. B., Chow, W., Ai, V. H. G., & Lam, K. S. L. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.255 · Cited by 54 · cited 1×
“20 Under physiological conditions, there is a balanced release of endothelial-derived relaxing and contracting factors, but this delicate balance is altered in diabetes and atherosclerosis, thereby contributing to further progression of vascular and end-organ damage”
Schram, M. T., van Ittersum, F. J., de Man, A., van Dijk, R. A. J. M., Schalkwijk, C., IJzerman, R. G., Twisk, J. W. R., & Stehouwer, C. D. A. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001812 · Cited by 53 · cited 1×
“In this issue of the Journal of Human Hypertension , Schram et al”
Fernández, R., Puig, J. G., Rodríguez-Pérez, J., Garrido, J. L. V., Redón, J., & on behalf of The TRAVEND Study Group (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001279 · Cited by 49
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’
Lip, G. Y. H., & Blann, A. D. (2004) · Annals of Medicine · doi:10.1080/07853890310021607 · Cited by 45 · cited 1×
“Thus, how can the relationships between inflammation and endothelial damagesdysfunction highlighted above be linked to atherosclerotic vascular disease in diabetes and hypertension? Inflammation is closely linked to thrombogenesis, and both are intimately linked to atherogenesis, and atherosclerosis has many similarit…”
Self-citationEfficacy of eprosartan in combination with HCTZ in patients with essential hypertension
Sachse, A., Verboom, C. N., & Jäger, B. A. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001317 · Cited by 42
Bakris, G. L., Smith, A. C., Richardson, D. J., Hung, E., Preston, R. A., Goldberg, R. B., & Epstein, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001315 · Cited by 41 · cited 1×
“For example, the beneficial effects of combining angiotensin converting enzyme (ACE) inhibitors with a nondihydropyridine calcium channel blockers are evident by greater reductions in proteinuria and similar preservation of renal morphology, when compared to either of its components alone”
Jonas, M., Reicher-Reiss, H., Boyko, V., Behar, S., & Grossman, E. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001597 · Cited by 36
Antihypertensive Therapy and Endothelial Function
Nadar, S. K., Blann, A., & Lip, G. Y. H. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382800 · Cited by 30 · cited 1×
“19 Endothelial cells release both relaxing and contracting factors that modulate vascular smooth muscle tone and also participate in the pathophysiology of essential hypertension”
Self-citationHow well are hypertension and albuminuria treated in type II diabetic patients?
Boero, R., Prodi, E., Elia, F., Porta, L., Martelli, S., Ferraro, L., & Quarello, F. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001568 · Cited by 17
Bakris, G. L., & White, D. (1997) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000398 · Cited by 15
Chin, B., & Lip, G. Y. H. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001184 · Cited by 9
Self-citation
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“inflammatory in nature [678-686], is related to the”
BackgroundIs Hypertension an Inflammatory Process?
Boos, C., & Lip, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776843313 · Cited by 165
“Another avenue of support for inflammation and hypertension hypothesis is the finding that inflammation can lead to increased arterial stiffness [144-150].”
BackgroundSelf-citationTowards understanding the aetiology and pathophysiology of human hypertension: where are we now?
Kakar, P., & Lip, G. Y. H. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002082 · Cited by 43
“16 In diabetic patients with hypertension, inflammation can be linked to urinary albumin excretion, as well as endothelial dysfunction”
Self-citationInsights into human hypertension: the role of endothelial dysfunction
Giansante, C., & Fiotti, N. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001951 · Cited by 26
Guo, H., & Zhang, L. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6178 · Cited by 21
“Inflammation is one of the most common characteristics of in patients with Type II diabetes (9), and is associated with the dysfunction of urinary albumin excretion, endothelial function and cellular metabolism (10).”
Metadata
- Authors
- Varughese, G. I., & Lip, G. Y. H.
- Affiliations
- Birmingham City Hospital (GB)
- Corresponding author
- Lip, G Y H
- Venue
- Journal of Human Hypertension
- Published
- 2005-04-07
- Volume
- 19
- Issue
- 6
- Pages
- 421-424
- ISSN
- 0950-9240 (ISSN-L)
- 1476-5527
- OpenAlex
- W2030369387
- Cited by
- 25
- References
- 32
- Citations by year
- 2025: 1 · 2018: 2 · 2017: 1 · 2015: 1 · 2012: 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Human Hypertension (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Sandwell and West Birmingham Hospitals NHS Trust
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- hypertension, type 2 diabetes, urinary albumin excretion, endothelial function, inflammation, diabetic nephropathy, vascular dysfunction
- MeSH terms
- Albuminuria, Antihypertensive Agents, Diabetes Mellitus, Type 2, Endothelium, Vascular, Humans, Hypertension, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.